Chiesi USA, INC.

Specialty pharmaceutical company; develops products for rare disease and specialty care

Based in NC

🤖

AI Overview

With $390K in lobbying spend across 15 quarterly filings, Chiesi USA, INC is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2020 to 2024.

$390K
Total Spend
5
Years Active
1
Firms Hired
5
Lobbyists Deployed
2
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2020$30K
2021$120K
2022$120K
2023$120K
2024$0

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Chiesi USA, INC. disclosed contacting in their lobbying filings.

HOUSE OF REPRESENTATIVESSENATEWhite House Office
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Pharmacy, Health Issues

Priority Review Voucher Program; FDA international inspections

FDA Inspections

H.R. 1730/S. 670, the Speeding Therapy Access Today (STAT) Act

H.R. 2623, Camerons Law

MACPAC Accelerated Approval Pathway Recommendations

Cures 2.0 (not introduced yet)

H.R. 6000, Cures 2.0 Act

H.R. 5376, the Build Back Better Act

H.R. 2623, Camerons Law

H.R. 482/ S. 350, the Newborn Screening Saves Lives Reauthorization Act

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.